INS and metabolic dysfunction-associated steatotic liver disease: Oral administration of A. actinomycetemcomitans in conjunction with high-fat diets in mice showed signs of non-alcoholic fatty liver disease (NAFLD) exacerbation through dysbiotic GI changes as well as higher insulin resistance and glucose intolerance [62].